Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10057268HBVENSG00000169006.7protein_codingNTSR2NoNo23620O95665
TVIS10057269HBVENSG00000169006.7protein_codingNTSR2NoNo23620O95665
TVIS44018754HTLV-1ENSG00000169006.7protein_codingNTSR2NoNo23620O95665
TCGA Plot Options
Drug Information
GeneNTSR2
DrugBank IDDB01106
Drug NameLevocabastine
Target IDBE0000464
UniProt IDO95665
Regulation Typepartial antagonist
PubMed IDs11723247; 8647296; 9080465
CitationsRichard F, Barroso S, Martinez J, Labbe-Jullie C, Kitabgi P: Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2. Mol Pharmacol. 2001 Dec;60(6):1392-8.@@Chalon P, Vita N, Kaghad M, Guillemot M, Bonnin J, Delpech B, Le Fur G, Ferrara P, Caput D: Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett. 1996 May 20;386(2-3):91-4.@@Botto JM, Guillemare E, Vincent JP, Mazella J: Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor. Neurosci Lett. 1997 Feb 28;223(3):193-6.
GroupsApproved; Investigational
Direct ClassificationPhenylpiperidines
SMILESC[C@@H]1CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@H]1CC[C@](CC1)(C#N)C1=CC=C(F)C=C1
PathwaysLevocabastine H1-Antihistamine Action
PharmGKBPA164742988
ChEMBLCHEMBL1615438